ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
AstraZeneca
University of Nebraska
Adela, Inc
Imperial College London
Elephas
Elephas
City of Hope Medical Center
Washington University School of Medicine
Travera Inc
Guardant Health, Inc.
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
The Christie NHS Foundation Trust
Singlera Genomics Inc.
Travera Inc
UNC Lineberger Comprehensive Cancer Center
DxTerity Diagnostics
Cancer Support Community, Research and Training Institute, Philadelphia
Charite University, Berlin, Germany
Wuhan Ammunition Life-tech Co., Ltd
Exact Sciences Corporation
Assistance Publique - Hôpitaux de Paris
TScan Therapeutics, Inc.
SpeciCare
M.D. Anderson Cancer Center
Swiss Cancer Institute
CureOne
Quantgene Inc.
Wake Forest University Health Sciences
Amgen
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Sandoz